维普中文期刊产品整合服务
51篇 您的检索式:作者名="CALVERLEY PMA"
    题名 作者 年代 出处 被引量
1Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary显示文摘Pauwels RA Buist AS Calverley PMA 2001Am J Respir Crit Care Med2001,163,5:1
2Global strat- egy for the diagnosis, management, and prevention of chr- onic obstructive pulmonary disease显示文摘Pauwels RA Buist AS Calverley PMA 2012Am J Respir Crit Care Med2012,163,5:1
3Global st- rategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease显示文摘Pauwels RA Buist AS Calverley PMA 2012American Jour- nal of Respiratory and Critical Care Medicine2012,163,5:1
4Impact of COPD in NorthAmerica and Europe in 2000:subjects'perspective of Confronting COPD International Survey显示文摘Rennard S DecramerM Calverley PMA 0,,06:1
5Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease显示文摘Pauwels RA Buist AS Calverley PMA 2001Am J Respir Crit Care Med2001,163,5:1
6The prevention ofchronic obstructive pulmonary disee exacerbations by salmeterol/fluticasone propionate or tiotropium Bromide 显示文摘Wedzicha JA Calverley PMA Seemungal TA 2008Am J Respir CritCare Med2008,177,:1
7The Prevention of Chronic Obstructive pulmonary disease exacerba- tions by salmeterol/fluticasone or tiotropium bromide 显示文摘WEDZICHA JA CALVERLEY PMA SEEMUNGAL TA 2008Am J Respir Crit Care Med J2008,177,3:1
8Pneumonia risk in COPDpatients receiving inhaled corticosteruids alone or in combination :TORCH study results显示文摘Crim C Calverley PMA Anderson JA 2009Eur Respir J2009,34,3:1
9Prevalence andprogression of osteoporosis in patients with COPD ; results fromtowards a revolution in COPD health study 显示文摘Ferguson GT Calverley PMA Anderson JA 2009Chest2009,136,6:1
10Pooled subpopulation analyses of the effects of roflumilast on exacerbations and lung function in COPD显示文摘Hanania NA Calverley PMA Dransfield MT 2014Respir Med2014,108,:1
11Salmeterol and flutieasone propionate and survival in chronic ob- structive pulmonary disease显示文摘Calverley PMA Anderson JA Celli B 2007N Engl J Med2007,356,:1
12Reduction of exacerbation by the PDE4 inhibitor roflumilast - the importance of defining different subsets of patients with COPD 显示文摘Rennard SI Calverley PMA Geohring UM 2011Respir Res2011,12,1:1
13Randomized double blind,placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease:the ISOLDE trial显示文摘Burge PS Calverley PMA Jones PW 2000BMI2000,320,7245:1
14Global strategy for the diagonosis, management,and prevention of chronic obstructive pulmonary disease显示文摘Pauwels RA BuistAS Calverley PMA 2001Am J Respir Crit Care Med2001,163,:1
15The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium Bromide显示文摘Wedzicha JA Calverley PMA Seemungal TA 2008Am J Respir Crit Care Med2008,177,:1
16Randomised,double blind,placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease:the ISOLDE trial显示文摘Burge PS Calverley PMA Jones PW 2000BMJ2000,320,:1
17Impact ol CUVI) m North America and Europe in 2000 : subjects'perspective of Con - fronting COPD International Survey 显示文摘Rennard S Decramer M Calverley PMA 2002Eur Respir J2002,20,6:1
18Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease显示文摘Calverley PMA Anderson JA Celli B 2007N Eng J Med2007,356,:1
19Chronic obstructive pulmonary disease显示文摘PMA Calverley Paul Walker 20032003 (9389)2003,,9389:1
20The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide 显示文摘Wedzicha JA Calverley PMA Seemungal TA 2008Am J Respir Crit Care Med2008,177,1:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费